Skip to main content

GOLDMAN SACHS GROUP INC

Position in PCRX — Pacira BioSciences, Inc.

CIK 886982 NEW YORK, NY

Position in PCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$38,743,262
+$3,263,161 QoQ
Shares Held
1,527,129
-2.7% QoQ
Ownership
3.83%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Derivatives in PCRX

reported options exposure · as of Jun 30, 2021
CallValue
$1,517,000
CallShares
25,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. PCRX ranks #15 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PCRX

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,743,262 1,527,129
2026-03-31 $35,480,101 1,569,916
2025-12-31 $33,654,014 1,300,387
2025-09-30 $33,758,389 1,309,988
2025-06-30 $31,282,733 1,308,901
2025-03-31 $27,454,179 1,104,796
2024-12-31 $13,883,704 736,927
2024-09-30 $5,167,913 343,383
2024-06-30 $10,095,610 352,870
2024-03-31 $6,339,395 216,954
2023-12-31 $6,851,041 203,054
2023-09-30 $5,299,509 172,735
2023-06-30 $7,693,159 191,993
2023-03-31 $7,472,882 183,114
2022-12-31 $4,865,554 126,018
2022-09-30 $6,387,161 120,082
2022-06-30 $6,361,054 109,109
2022-03-31 $8,117,394 106,360
2021-12-31 $10,628,066 176,634
2021-09-30 $24,398,416 435,686
2021-06-30 $1,517,000 25,000
2021-06-30 $24,666,722 406,505
2021-03-31 $1,752,250 25,000
2021-03-31 $26,111,187 372,538
2020-12-31 $24,545,111 410,179
2020-09-30 $17,407,023 289,538
2020-06-30 $12,739,977 242,805
2020-03-31 $11,655,933 347,627